Skip to content
healthcare.dev
Get a free key

Nateglinide

NDC 71209-030, Nateglinide, tablet, coated, from Cadila Pharmaceuticals Limited.

Product NDC
71209-030
Status
Listed
Labeler
Cadila Pharmaceuticals Limited
Dosage form
TABLET, COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206432
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71209-030 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NATEGLINIDE60 mg/1

Pharmacologic classes

Glinide [EPC]; Potassium Channel Antagonists [MoA]

Package NDCNDC-11Package
71209-030-047120900300490 TABLET, COATED in 1 BOTTLE (71209-030-04)
71209-030-0571209003005100 TABLET, COATED in 1 BOTTLE (71209-030-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c678b772-acba-4b59-a0b2-d70d84283425

Use it

Look up 71209-030 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71209-030 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71209-030. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.